StonvexLoading…
StonvexStonvexStonvexCore line items from LEGH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $21.55M | $116.93M | $91.46M | $62.68M |
Operating Income | $12.39M | $48.41M | $38.12M | $28.41M |
Net Income | $10.93M | $41.81M | $33.62M | $14.70M |
EPS (Diluted) | $0.46 | $1.74 | $1.37 | $1.01 |
Total Assets | $591.47M | $580.34M | $557.93M | $551.99M |
Total Liabilities | $52.48M | $51.72M | $36.33M | $39.20M |
Cash & Equivalents | $14.11M | $8.48M | $13.55M | $2.63M |
Free Cash Flow OCF − CapEx | $5.42M | $28.15M | $12.46M | $7.33M |
Shares Outstanding | 23.78M | 23.81M | 23.87M | 23.87M |